Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
about
KSHV-Mediated Angiogenesis in Tumor ProgressionKSHV Genome Replication and MaintenanceCo-infections and Pathogenesis of KSHV-Associated MalignanciesA Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA ProteinsEpstein-Barr Virus: Diseases Linked to Infection and TransformationViral Genome Tethering to Host Cell Chromatin: Cause and ConsequencesRecapitulation of acquired immuno deficiency syndrome associated Kaposi's sarcomaKSHV reactivation and novel implications of protein isomerization on lytic switch controlInduction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.Viral miRNA targeting of bicistronic and polycistronic transcriptsHIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway.A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infectionCis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.KSHV LANA--the master regulator of KSHV latency.Molecular biology of KSHV lytic reactivation.KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathwaysA novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells.Chromatinization of the KSHV Genome During the KSHV Life Cycle.Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda.Identification of the Essential Role of Viral Bcl-2 for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation.Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK.Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic ReplicationDownregulation of Poly(ADP-Ribose) Polymerase 1 by a Viral Processivity Factor Facilitates Lytic Replication of Gammaherpesvirus.A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing GlycolysisKSHV-Mediated Regulation of Par3 and SNAIL Contributes to B-Cell ProliferationRNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature.Kaposi's Sarcoma-Associated Herpesvirus Reduces Cellular Myeloid Differentiation Primary-Response Gene 88 (MyD88) Expression via Modulation of Its RNA.Exploitation of Cellular Cytoskeletons and Signaling Pathways for Cell Entry by Kaposi's Sarcoma-Associated Herpesvirus and the Closely Related Rhesus Rhadinovirus.Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.High Glucose Induces Reactivation of Latent Kaposi's Sarcoma-Associated HerpesvirusGenomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAsInteractome mapping: using protein microarray technology to reconstruct diverse protein networks.Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition.Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses.
P2860
Q26742030-0117E03E-8A15-48DE-BD8E-066075B0A9EAQ26766437-66D6DC56-60FC-4003-8140-FA7A8FD5A488Q26766493-135F92FF-5276-4E08-9C2F-F835F159A658Q27680409-2003E471-7C94-40CF-A3C7-CFF3038247CCQ28074586-83DD7CE7-3A1C-40CA-A5FB-24C1D61D55ECQ28079650-DB3D7D2D-DCC5-47A4-AB39-2C83C4C0E7B0Q28080182-3A28D3F0-005F-49F9-A6D4-914884C6FEDCQ28080937-40DB274A-5C6C-4AE7-A9D7-C6655C5C5455Q30357883-8C47DC69-CA3A-4A49-9A61-D68655A4DE04Q33744019-615975AF-FC96-45EE-B9E2-359BF56D2E48Q33887681-706608B8-F125-49F6-B424-B7D40C36AED8Q34112086-9F123190-4868-49D4-B4CB-83FEC31A2CA8Q34115364-B2CE402A-F269-4B98-B72D-E18AD8AADBEEQ34179693-33D5E592-5F3C-4676-8AA0-BCC5EAF98880Q34257818-AD942A5A-2FC8-4857-AFBC-D5CC9A32DAA8Q34743747-3BF8E495-3D17-4337-B5F7-20A70A49A083Q34774797-C83A0E2C-4382-48C9-87C2-36B5F482E470Q35014918-C438117C-E55B-4BDC-BF3F-90754F183DD5Q35079842-38ECC06F-3F6C-4321-AE61-BBCCE4D0B962Q35161728-25955489-07FF-4628-8647-AE0D586C7727Q35237492-636DD3F5-9316-4BE2-88B8-A3293A03DAEEQ35328464-790D77CA-361C-483F-84BF-829560815CFFQ35641400-07A1602B-41D0-4E29-95F5-30685A50C520Q35641410-4BFFE212-5B9E-4B34-9B52-4343D48E3A03Q35675995-CFE6E2DC-D7F9-46B0-8738-7532456C3E48Q35927487-15F2B6DA-706D-4680-954D-6D3A4EAF7FB2Q35973546-9F499387-2F92-430C-9F70-E95DD055C7ECQ35983671-9B1689CD-D41B-44E6-BABE-A8C68BEDDC2CQ36019773-C01CA8EE-46B7-4B54-9FAC-22BD604A32F5Q36087231-012EC341-D47F-407F-99EE-BE3A6488429AQ36238539-98446F76-5E77-4AEF-BFA4-9531CBAFF89DQ36433837-FD01DC83-88DC-41C0-BEFA-C40409773FBCQ36607885-2D14E3AE-10D1-457C-9750-494168428ADCQ37073302-85A6A522-2A4E-4878-AF42-F811738B08EFQ37347292-83780652-6401-40B7-9005-BEFA6F17847EQ37547788-A8748FDC-6D52-4820-8B3B-60647C3B5968Q37671058-92E1A200-149E-45CE-AAEF-94D034628306Q37692599-C568C3B9-2932-4DA3-9C66-AA7B0E63AE0AQ37714039-828E3A76-5C80-4B65-AEB6-726DFCCBB11FQ38048861-C6F3C6F1-266C-4B6E-A495-6DB7D7157425
P2860
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
@ast
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
@en
type
label
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
@ast
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
@en
prefLabel
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
@ast
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
@en
P2860
P356
P1433
P1476
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
@en
P2093
Fengchun Ye
Xiufen Lei
P2860
P356
10.1155/2011/193860
P577
2011-01-01T00:00:00Z